AAAAAA

   
Results: 1-2 |
Results: 2
Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells
Authors: Thiesing, JT Ohno-Jones, S Kolibaba, KS Druker, BJ
Citation: Jt. Thiesing et al., Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells, BLOOD, 96(9), 2000, pp. 3195-3199
CRKL binding to BCR-ABL and BCR-ABL transformation
Authors: Kolibaba, KS Bhat, A Heaney, C Oda, T Druker, BJ
Citation: Ks. Kolibaba et al., CRKL binding to BCR-ABL and BCR-ABL transformation, LEUK LYMPH, 33(1-2), 1999, pp. 119-126
Risultati: 1-2 |